In addition, ROR1 was found in CD34+ acute myeloid leukemia (AML) cells and can be targeted by mAbs (39).In addition to hematological malignancies, aberrant expression of ROR1 was also found in a wide range of solid tumors as a biomarker and therapeutic target (7, 40). The gene discussed is ROR1; the disease is hematologic disorder.